NCT03878199 2026-04-24Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative NeoplasmsOhio State University Comprehensive Cancer CenterPhase 1/2 Terminated12 enrolled 15 charts